 REDWOOD CITY, Calif., Dec. 28, 2020 PRNewswire -- Nevro Corp. NYSE: NVRO, a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the company has submitted a pre-market approval supplement to the... 